CSF2RB and lung carcinoma: However, in 321 “exclude those never smoked” female lung cancer patients, no significant difference was observed between 161 patients with high expression and 160 patients with low expression of CSF2RB (Fig. 4B, log-rank P = .501; HR = 0.89; 95% CI: 0.63–1.25).